Change in CD4+ T Cell Count
Group RH
After 12 weeks of RE therapy and HAART, the mean CD4+ T lymphocyte count increased by 151.7 cells/μL (p = 0.0004). Of the 20 subjects, CD4+ T lymphocyte count increased in 18 and decreased in 2.
Group H
After 12 weeks of HAART, the mean CD4+ T lymphocyte count decreased by 23.1 cells/μL (p = 0.473). Of the 20 subjects, CD4+ T lymphocyte count increased in 13 and decreased in 7.
Group R
After 12 weeks of HAART, the mean CD4+ T lymphocyte count increased by 98.0 cells/μL (p = 0.099). Of the 20 subjects, CD4+ T lymphocyte count increased in 6 and decreased in 4.
Group U
After 12 weeks in the untreated group, the mean CD4+ T lymphocyte count decreased by 42.4 cells/μL (p = 0.528). Of the 10 subjects, CD4+ T lymphocyte count increased in 4, remained unchanged in 1, and decreased in 5.
Implication from the Above Outcomes
The above outcomes showed that combining HAART with RE therapy effectively increased CD4+ T cell count.